Time
|
Duration
|
Type
|
Presenting person
|
Title
|
May 30th, Wednesday |
|
| 09:00 |
00:45:00 |
Invited oral |
Janusz Obukowicz |
Pharmaceutical technologies – why do they have to be innovative |
| 09:45 |
00:45:00 |
Invited oral |
Jerzy Boryski |
Pyrimidine nucleoside analogues with appended heterocylic ring and their antiviral properties |
| 10:50 |
00:45:00 |
Invited oral |
Aleksander P. Mazurek |
Nanotechnolgy in pharmacy and medicine – contemporary status and future perspectives |
| 11:35 |
00:20:00 |
Oral |
Ewa B. Bębenek |
Synthesis and anticancer activity of acetylenic derivatives of betulin |
| 11:55 |
00:20:00 |
Oral |
Ewelina M. Błońska-Sikora |
The influence of crenotherapy on glutathione level in human body. |
| 12:15 |
00:20:00 |
Oral |
Teresa M. Brodniewicz |
Plant phenolics as new drug leads. What’s missing? |
| 12:35 |
00:20:00 |
Oral |
Tomasz Rzymski |
SEL-120-small molecule CDK8/9 kinase inhibitors as potential targeted therapy in colorectal cancer treatment. |
| 14:30 |
00:45:00 |
Invited oral |
Jerzy Ostrowski |
Molecular medicine - Facts and myths |
| 15:15 |
00:20:00 |
Oral |
Marcin Gawryś |
Impurity profiling using 2D-HPLC-IT-TOF |
| 15:35 |
00:20:00 |
Oral |
Katarzyna E. Filip |
Genotoxic impurities in pharmaceuticals |
| 15:55 |
00:20:00 |
Oral |
Marek Wasek |
The analysis of plant-based raw materials of the unknown origin |
| 16:15 |
00:20:00 |
Oral |
Maciej Serda |
Iron chelators- the novel perspective in cancer treatment |
May 31st, Thursday |
|
| 09:00 |
00:45:00 |
Invited oral |
Matthias Bochtler |
The link between CpG methylation and depletion and a new CpG specific methyltransferase |
| 10:50 |
00:45:00 |
Invited oral |
Zbigniew J. Leśnikowski |
New trends in search for bioactive compounds: EU-OPENSCREEN and boron clusters. |
| 11:35 |
00:20:00 |
Oral |
Maria Puchalska |
Development and validation of HPLC method. Review of selected cases. |
| 11:55 |
00:20:00 |
Oral |
Monika Lamparska-Przybysz |
CPL-200-075, a novel potent renal sodium-glucose cotransporter 2 (SGLT2) inhibitor |
| 12:15 |
00:20:00 |
Oral |
Kamil K. Kamiński |
Dextran-based materials reducing anticoagulant activity of heparin in animal models in vitro and in vivo |
| 12:35 |
00:20:00 |
Oral |
Robert Musiol |
Quinoline based antifungals |
| 14:30 |
00:45:00 |
Invited oral |
Stefan Chłopicki |
Experimental pharmacology of endothelium: MNA/COX-2/PGI2 pathway |
| 15:15 |
00:20:00 |
Oral |
Zofia Lipkowska |
Supramolecular assembly and properties of dendrimeric peptide mimics |
| 15:35 |
00:20:00 |
Oral |
Dorota Maciejewska |
The molecularly imprinted polymers as selective
sorbents to pharmaceutical analyses |
| 15:55 |
00:20:00 |
Oral |
Katarzyna Sidoryk |
Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents. |
| 16:15 |
00:20:00 |
Oral |
Filip Stefaniak |
Design and development of CPL-407-22 – novel, potent and selective JAK2 protein kinase inhibitor. |
June 1st, Friday |
|
| 08:40 |
00:20:00 |
Oral |
Ryszard Ostaszewski |
Studies toward Novel Peptidomimetc Inhibitors of Thioredoxin-Thiredoxin Reductase System |
| 09:00 |
00:45:00 |
Invited oral |
Wiesław Szeja |
Sugars in new drug design. Sugar moiety structure as a principal determinant of antitumor glycoconjugates biological activity. |
| 09:45 |
00:45:00 |
Invited oral |
Mariusz Kondrat |
Legal protection of borderline products in reference to food supplements and pharmaceuticals. |
| 10:50 |
00:45:00 |
Invited oral |
Lech Kozerski |
Molecular complexes of topo I and II inhibitors from camptothecin and flavonoid families with model DNA oligomers. Search for sequence specific binding. Verification of biological assays on atomic coordinates level. |
| 11:35 |
00:45:00 |
Invited oral |
Bartłomiej Furman |
Diastereoselective Synthesis of β-Lactams via Kinugasa Reaction |
| 12:20 |
00:20:00 |
Oral |
Michał Fedoryński |
Synthesis of trans-4-cyclohexyl-(S)-proline - an intermediate in Fosinopril process |
| 12:40 |
00:20:00 |
Oral |
Anita Płazińska |
Differential aspects of molecular interactions fenoterol stereoisomers and derivatives with the β2-adrenergic receptor |
| 14:30 |
00:45:00 |
Invited oral |
Piotr Pawluć |
Application of the Silylative Coupling Reaction in Organic Synthesis |
| 15:15 |
00:20:00 |
Oral |
Elżbieta Hejchman |
Synthesis and anticancer properties of coumarin gallates |
| 15:35 |
00:20:00 |
Oral |
Katarzyna Wiktorska |
Sulforaphane - a modulator of detoxifying enzymes can alter medicines effectiveness. |
| 15:55 |
00:20:00 |
Oral |
Anna Mrozek-Wilczkiewicz |
Studies on anticancer iron chelators |
| 16:15 |
00:20:00 |
Oral |
Piotr J. Rudzki |
Validation of bioanalytical methods according to new European Medicines Agency guideline |
| 16:35 |
00:20:00 |
Oral |
Andrzej Kutner |
A novel convergent synthesis of the prostaglandin F2α analogues |
